Table 1.

Baseline characteristics

VariableDaily Trial Analytic CohortaP ValueNocturnal Trial Analytic CohortaP Value
Three Times per Week (n=77)Six Times per Week (n=96)Three Times per Week (n=39)Six Times per Week (n=41)
Age, yr51.2±13.950.8±13.70.8355.0±12.252.6±14.40.42
Men43 (56%)54 (56%)0.9625 (64%)27 (66%)0.87
Race/ethnicity
 Black27 (35%)38 (40%)0.549 (23%)11 (27%)0.69
 White34 (44%)33 (34%)0.1921 (54%)24 (59%)0.67
 Hispanic/Latino24 (31%)29 (30%)0.890 (0%)0 (0%)
Duration of ESRD, yr3.5 (1.8, 6.9)3.6 (1.4, 8.1)0.850.5 (0.2, 3.6)1.3 (0.3, 3.3)0.29
Diabetes36 (47%)46 (48%)0.8818 (46%)17 (42%)0.67
Hypertension72 (94%)89 (93%)0.8436 (92%)38 (93%)0.95
Serum album (g/dl)3.9±0.53.9±0.40.783.9±0.53.9±0.50.81
Cousineau score37.7±23.037.1±27.60.9032.9±18.332.0±19.70.85
Beck depression inventory13.5±9.913.4±9.10.9511.7±8.710.9±8.00.69
RAND-36 PHC35.8±9.336.0±10.70.9138.0±8.637.3±9.70.76
RAND-36 MHC44.8±9.942.7±13.50.2547.0±11.346.1±10.40.72
Travel time to dialysis, min20.0 (15.0, 30.0)23.5 (15.0, 30.0)0.8530.0 (20.0, 59.0)30.0 (15.0, 45.0)0.33
  • Values are means±SDs or medians (25th, 75th percentiles). PHC, physical health composite; MHC, mental health composite.

  • a The analytic cohort is those patients that had a Cousineau score at any point during baseline or follow-up.